Logo image of CXE

MFS HIGH INCOME MUNICIPAL TR (CXE) Stock Price, Quote, News and Overview

NYSE:CXE - New York Stock Exchange, Inc. - US59318D1046 - Currency: USD

3.53  0 (0%)

After market: 3.5 -0.03 (-0.85%)

Fundamental Rating

2

Overall CXE gets a fundamental rating of 2 out of 10. We evaluated CXE against 0 industry peers in the Unkown industry. CXE has a bad profitability rating. Also its financial health evaluation is rather negative. CXE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CXE was profitable.
In the past year CXE had a positive cash flow from operations.
Of the past 5 years CXE 4 years were profitable.
CXE had a positive operating cash flow in each of the past 5 years.
CXE Yearly Net Income VS EBIT VS OCF VS FCFCXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

Industry RankSector Rank
ROA 7.45%
ROE 11.91%
ROIC 1.91%
ROA(3y)-2.46%
ROA(5y)-0.5%
ROE(3y)-4.33%
ROE(5y)-1.01%
ROIC(3y)1.98%
ROIC(5y)2.07%
CXE Yearly ROA, ROE, ROICCXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

CXE's Profit Margin has improved in the last couple of years.
CXE's Operating Margin has declined in the last couple of years.
CXE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 48.87%
PM (TTM) 160.69%
GM 47.29%
OM growth 3Y-10.6%
OM growth 5Y-4.76%
PM growth 3Y9.73%
PM growth 5Y5.18%
GM growth 3Y-12.37%
GM growth 5Y-5.98%
CXE Yearly Profit, Operating, Gross MarginsCXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1

2. Health

2.1 Basic Checks

CXE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CXE has been increased compared to 5 years ago.
The debt/assets ratio for CXE has been reduced compared to a year ago.
CXE Yearly Shares OutstandingCXE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CXE Yearly Total Debt VS Total AssetsCXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 0.75, we must say that CXE is in the distress zone and has some risk of bankruptcy.
The Debt to FCF ratio of CXE is 12.32, which is on the high side as it means it would take CXE, 12.32 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.50 indicates that CXE is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 12.32
Altman-Z 0.75
ROIC/WACCN/A
WACCN/A
CXE Yearly LT Debt VS Equity VS FCFCXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

CXE has a Current Ratio of 0.02. This is a bad value and indicates that CXE is not financially healthy enough and could expect problems in meeting its short term obligations.
CXE has a Quick Ratio of 0.02. This is a bad value and indicates that CXE is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
CXE Yearly Current Assets VS Current LiabilitesCXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 550.00% over the past year.
CXE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.40% yearly.
The Revenue has decreased by -0.88% in the past year.
CXE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.11% yearly.
EPS 1Y (TTM)550%
EPS 3Y7.74%
EPS 5Y-0.4%
EPS Q2Q%1650%
Revenue 1Y (TTM)-0.88%
Revenue growth 3Y-1.33%
Revenue growth 5Y-5.11%
Sales Q2Q%1.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CXE Yearly Revenue VS EstimatesCXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

2

4. Valuation

4.1 Price/Earnings Ratio

CXE is valuated cheaply with a Price/Earnings ratio of 6.79.
Compared to an average S&P500 Price/Earnings ratio of 26.69, CXE is valued rather cheaply.
Industry RankSector Rank
PE 6.79
Fwd PE N/A
CXE Price Earnings VS Forward Price EarningsCXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 19.88
EV/EBITDA N/A
CXE Per share dataCXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.09%, CXE is a good candidate for dividend investing.
CXE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.43.
Industry RankSector Rank
Dividend Yield 5.09%

5.2 History

The dividend of CXE decreases each year by -6.93%.
CXE has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of CXE decreased recently.
Dividend Growth(5Y)-6.93%
Div Incr Years1
Div Non Decr Years1
CXE Yearly Dividends per shareCXE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

CXE pays out 34.70% of its income as dividend. This is a sustainable payout ratio.
CXE's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP34.7%
EPS Next 2YN/A
EPS Next 3YN/A
CXE Yearly Income VS Free CF VS DividendCXE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M
CXE Dividend Payout.CXE Dividend Payout, showing the Payout Ratio.CXE Dividend Payout.PayoutRetained Earnings

MFS HIGH INCOME MUNICIPAL TR

NYSE:CXE (6/25/2025, 8:04:00 PM)

After market: 3.5 -0.03 (-0.85%)

3.53

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners42.38%
Inst Owner Change3.32%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap111.30M
Analysts0
Price TargetN/A
Short Float %0.07%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield 5.09%
Yearly Dividend0.18
Dividend Growth(5Y)-6.93%
DP34.7%
Div Incr Years1
Div Non Decr Years1
Ex-Date06-17 2025-06-17 (0.018)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.79
Fwd PE N/A
P/S 10.97
P/FCF 19.88
P/OCF 19.88
P/B 0.81
P/tB 0.81
EV/EBITDA N/A
EPS(TTM)0.52
EY14.73%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.18
FCFY5.03%
OCF(TTM)0.18
OCFY5.03%
SpS0.32
BVpS4.35
TBVpS4.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.45%
ROE 11.91%
ROCE 2.41%
ROIC 1.91%
ROICexc 1.91%
ROICexgc 1.91%
OM 48.87%
PM (TTM) 160.69%
GM 47.29%
FCFM 55.17%
ROA(3y)-2.46%
ROA(5y)-0.5%
ROE(3y)-4.33%
ROE(5y)-1.01%
ROIC(3y)1.98%
ROIC(5y)2.07%
ROICexc(3y)1.98%
ROICexc(5y)2.07%
ROICexgc(3y)1.98%
ROICexgc(5y)2.07%
ROCE(3y)2.5%
ROCE(5y)2.62%
ROICexcg growth 3Y-3.76%
ROICexcg growth 5Y-4.63%
ROICexc growth 3Y-3.76%
ROICexc growth 5Y-4.63%
OM growth 3Y-10.6%
OM growth 5Y-4.76%
PM growth 3Y9.73%
PM growth 5Y5.18%
GM growth 3Y-12.37%
GM growth 5Y-5.98%
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 12.32
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 34.33%
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 0.75
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)550%
EPS 3Y7.74%
EPS 5Y-0.4%
EPS Q2Q%1650%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.88%
Revenue growth 3Y-1.33%
Revenue growth 5Y-5.11%
Sales Q2Q%1.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.43%
EBIT growth 3Y-11.78%
EBIT growth 5Y-9.63%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.99%
FCF growth 3Y-10.79%
FCF growth 5Y-6.58%
OCF growth 1Y-43.99%
OCF growth 3Y-10.79%
OCF growth 5Y-6.58%